Amneal Pharmaceuticals
AMRX
AMRX
156 hedge funds and large institutions have $202M invested in Amneal Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more capital invested
Capital invested by funds: $200M → $202M (+$2.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less call options, than puts
Call options by funds: $119K | Put options by funds: $149K
Holders
156
Holding in Top 10
1
Calls
$119K
Puts
$149K
Top Buyers
1 | +$7.59M | |
2 | +$6.04M | |
3 | +$5.4M | |
4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.32M |
5 |
Bank of America
Charlotte,
North Carolina
|
+$1.74M |
Top Sellers
1 | -$7.73M | |
2 | -$7.68M | |
3 | -$5.55M | |
4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$1.98M |
5 |
Citadel Advisors
Miami,
Florida
|
-$1.9M |